Fibrinogen: Clinical Trials

16 trials of Fibrinogen, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed, 2 unknown, 2 withdrawn, 1 terminated. 16 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 316Completed 11, Unknown 2, Withdrawn 2, Terminated 1
Phase 22Completed 2

Follow Fibrinogen: new trials by email Literature Review of Fibrinogen trials Research Report on Fibrinogen

Trials (filtered) newest first · largest first

All 16 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
FIB Grifols Congenital Deficiency for On-demand Treatment and Surgical Prophylaxis
FIB Grifols - Congenital Afibrinogenemia, Hypofibrinogenemia
Phase 3WithdrawnInstituto Grifols, S.A.2023-12-012023-10-23
Fibrinogen Early In Severe Trauma StudY II
Fibrinogen Concentrate, Cryoprecipitate - Trauma, Haemorrhagic Shock
Phase 3CompletedAustralian and New Zealand Intensive Care Research Centre9002022-11-212026-09-09
In Vivo Effects of Fibrinogen Concentrate (FC) Versus Cryoprecipitate on the Neonatal Fibrin Network Structure After Cardiopulmonary Bypass (CPB)
Fibrinogen Concentrate (FC), Cryoprecipitate - Hemostasis
Phase 3CompletedEmory University362019-08-132024-02-20
Study to Assess the Efficacy, Safety and Pharmacokinetic of Octafibrin in Paediatric Subjects With Fibrinogen Deficiency
Octafibrin - Congenital Fibrinogen Deficiency
Phase 3CompletedOctapharma152015-12-012021-01-15
Prospective Double Blinded Randomized Control Study of the Use of Fibrinogen in High-Risk Cardiac Surgery
Fibrinogen - Cardiac Complication During Procedure
Phase 3CompletedNova Scotia Health Authority622014-02-012020-05-22
The Efficacy of the Administration of Fibrinogen in Liver Transplantation
Fibrinogen, Saline - Intraoperative Bleeding
Phase 3UnknownHospital Universitari de Bellvitge1322012-07-012014-12-04
The Clinical Effect of i-FACTOR® Versus Allograft in Non-instrumented Posterolateral Spondylodesis Operation in the Elderly With Spinal Stenosis Due to Degenerative Spondylolisthesis
i-FACTOR - Spinal Stenosis
Phase 3UnknownSygehus Lillebaelt1082012-03-012016-09-07
RETIC Trial: Reversal of Trauma Induced Coagulopathy Using Coagulation Factor Concentrates or Fresh Frozen Plasma
Fibrinogen concentrate, Prothrombin complex concentrate and FXIII concentrate, Fresh Frozen Plasma blood type 0, A, B and AB - Major Trauma
Phase 3TerminatedMedical University Innsbruck1002012-03-012016-03-23
Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery
Fibrinogen Concentrate (Human) (FCH), Placebo - Surgical Blood Loss, Postoperative Blood Loss
Phase 3CompletedCSL Behring1522012-01-012014-09-18
The ZEro PLASma Trial (ZEPLAST): Avoidance of Fresh Frozen Plasma in Cardiac Surgery
Fibrinogen, Saline solution, Prothrombin complex - Heart Disease
Phase 3CompletedIRCCS Policlinico S. Donato1192011-11-012015-03-31
Fibrinogen Concentrate as Initial Treatment for Postpartum Haemorrhage: A Randomised Clinically Controlled Trial
Fibrinogen Concentrate, Isotonic Saline - Postpartum Haemorrhage
Phase 2 / Phase 3CompletedCopenhagen University Hospital at Herlev2492011-05-012013-09-20
Haemocomplettan® P During Elective Complex Cardiac Surgery
Haemocomplettan® P, Human albumin (Placebo) - Fibrinogen Deficiency in Complex Cardiac Surgery
Phase 2 / Phase 3CompletedIsala1202011-02-012014-12-16
Fibrinogen Concentrate (Human) - Efficacy and Safety Study
Fibrinogen Concentrate, Human (FCH), Cryoprecipitate - Afibrinogenemia, Hypofibrinogenemia
Phase 3WithdrawnCSL Behring2009-10-012023-02-06
TachoSil Versus Standard Surgical Treatment for Air Leakage in Pulmonary Lobectomy (TC-021-IM)
Fibrinogen (human) + thrombin (human) (TachoSil) - Pulmonary Diseases, Intraoperative Complications
Phase 3CompletedNycomed2006-02-012012-05-07
TachoSil Paediatric Liver Trial (TC-019-IN)
Fibrinogen human (TachoSil) - Liver Diseases
Phase 3CompletedNycomed162005-10-012012-05-07
TachoComb S Versus Standard Surgical Treatment in Surgical Resection of Renal Tumour (TC-015-IN)
Fibrinogen (human) + thrombin (human) (TachoSil) - Surgical Resection of Superficial Renal Tumour
Phase 3CompletedTakeda1702012-08-03

Conditions studied

Hemostatic Disorders (3)  ·  Afibrinogenemia (2)  ·  Blood Loss, Surgical (2)  ·  Heart Diseases (1)  ·  Hemorrhage (1)  ·  Intraoperative Complications (1)  ·  Liver Diseases (1)  ·  Lung Diseases (1)  ·  Postoperative Hemorrhage (1)  ·  Postpartum Hemorrhage (1)  ·  Shock, Hemorrhagic (1)  ·  Signs and Symptoms (1)  ·  Spinal Stenosis (1)  ·  Thrombosis (1)  ·  Wounds and Injuries (1)

Sponsors

CSL Behring (2)  ·  Nycomed (2)  ·  Australian and New Zealand Intensive Care Research Centre (1)  ·  Copenhagen University Hospital at Herlev (1)  ·  Emory University (1)  ·  Hospital Universitari de Bellvitge (1)  ·  IRCCS Policlinico S. Donato (1)  ·  Instituto Grifols, S.A. (1)  ·  Isala (1)  ·  Medical University Innsbruck (1)  ·  Nova Scotia Health Authority (1)  ·  Octapharma (1)  ·  Sygehus Lillebaelt (1)  ·  Takeda (1)

Countries

Denmark (6)  ·  Austria (2)  ·  Canada (2)  ·  Italy (2)  ·  Australia (1)  ·  Brazil (1)  ·  Czechia (1)  ·  Finland (1)  ·  Germany (1)  ·  India (1)  ·  Iran (1)  ·  Japan (1)  ·  Lebanon (1)  ·  Netherlands (1)  ·  New Zealand (1)

Top investigators

Anne J. Wikkelsoe, MD (1)  ·  Antoni Sabate, MD (1)  ·  Arash Afshari, MD (1)  ·  Arno P Nierich, MD, PhD. (1)  ·  Cristina Solomon, MD (1)  ·  Hellen McKinnon Edwards, M.D. (1)  ·  Jakob Stensballe, MD, PhD (1)  ·  Jens Langhoff-Roos, MD, DmSc (1)  ·  Laura Downey, MD (1)  ·  Marco Ranucci, MD (1)  ·  Michael K Jacobsen, MD (1)  ·  Myron Kwapisz, MD (1)  ·  Niels Rahe-Meyer, MD, PhD (1)

Results publications

PMID 22805300, PMID 25586727, PMID 26037084, PMID 26880105, PMID 27317703, PMID 28241354, PMID 28457980, PMID 28990201, PMID 30462259, PMID 37919695, PMID 39116012, PMID 39152310, PMID 40420619

NIH funding

2004 (2), 2009 (1), 2018 (1)